National and Kapodistrian University of Athens
Μελέτη αποπτωτικών δεικτών και δεικτών πολλαπλασιασμού σε σχέση με την επιβίωση ασθενών με καρκίνο πνεύμονα
Abstract
dc:descriptionMalignant neoplasms generally arise from a multistep process characterized by various genetic alterations. Molegular genetic studies have revealed mutations in a number of oncogenes and tumor suppressor genes in malignant neoplasms. It has been demonstrated that tumor growth and aggressiveness may be determined by the proliferative rate, as well as by the rate of cell death, or apoptosis. Apoptosis plays a key role in the development of malignant tumors. The protein products of the bcl-2 and p53 genes are the most relevant proteins in apoptosis and tumor development. Telomerase is a specialized ribonucleoprotein polymerase that function in the maintenance of telomeres and is considered to be necessary for the indefinite proliferation of human cancer cells. Progressive shortening of telomeres and activation of telomerase have been considered to be one of the key mechanisms in chromosome structural integrity, cellular immortalization and tumor progression. The aim of this study was to examine the expression of bcl-2, p53 and Telomerase immunohistochemically in tumor’s tissues from patients with lung cancer in order to assess their correlation with clinicopathological features and the overall survival of the patients. The tumor’s tissues were obtained from patients with lung cancer during their the diagnostic bronchoscopy. Immunostaining was performed in 75 tissue samples from patients in whom follow up was completed. There were 67( 89.3%) male and(10.7% ) female. Their age raged from 40 to 85 years old ( mean 64.05± 8.93 ). Most of the patients were smokers 69.3%, or former smokers (28%). Histological classification and grade were assessed by light microscopy according to WHO criteria. The most common histological type was squamous cell carcinoma (45,3%) followed by small cell carcinoma (28%). For the present study , immunohistochemically stained sections were judged positive for bcl-2 and p53 expression when >10% of the cancer cells showed cytoplasmic and nucleolar staining respectively. Telomerase activity was judged as moderate positive when 10-50% of the cancer cells were positive and strong positive when > 50% of the cells were positive. All slides were evaluated for immunostaining in a blinded fashion without any knowledge of the clinical outcome or other clinicopathological data. Positive p53 expression was found in 14( 66.6%) patients with SCLC and 37 ( 68.5%) with NSCLC. No correlation was found between p53 expression and histological type ( p=0.877). Positive expression for bcl-2 was found in 6 (28%) of the patients with SCLC and 19( 35%) of the patients with NSCLC. No correlation was also found between bcl-2 expression and histological type. Moderate expression of Telomerase was found in 7( 33.3%) of the patients with SCLC and 15(27.7%) of the patients with NSCLC. Strong expression of Telomerase was found in 8( 38%) and 20(37%) respectively. No correlation between Telomerase expression and histological type was found as well. A significant positive correlation was observed between tumor size (T ) and Telomerase activity (p=0.017), but in the case of bcl-2 or p53 expression no correlation was found p=0.230 and p=0.647 respectively.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Viskos, Alexandros-Ioannis
- Βίσκος, Ιωάννης-Αλέξανδρος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18496